Most previous studies examined the distribution of individual biomarkers; for instance, the proportions of elevated NT-proBNP, hs-cTNT, and hsCRP were over two thirds (19), the rates of renal dysfunction were 40–50% (20), and the prevalence of DM, anemia, and dyslipidemia were 20, 26, and 50% (21), respectively. The gene discussed is NPPB; the disease is metabolic syndrome.